FDA
-
-
-
-
-
-
-
Apotex launches sitagliptin tablets and sitagliptin and metformin hydrochloride tablets, eligible for 180-day shared exclusivity
-
-
-
-
-
-
-
Merck Highlights New Long-Term Data and Advancements Across Broad Oncology Portfolio and Pipeline Research at ASCO 2026
-
-
-
-
-
-
-
Merck and Eisai report failed kidney cancer drug trial results
-
-
-
-
-
-
-
European Commission Approves Merck’s ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants During Their First RSV Season
-
-
-
-
-
-
-
Merck's WINREVAIR shows promise in heart failure trial
-
-
-
-
-
-
-
FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs
-
-
-
-
-
-
-
Merck (MRK) PT Raised to $129 at Leerink Partners
-
322,996 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

